Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
63.82
+0.83 (1.32%)
May 2, 2025, 12:03 PM EDT - Market open
Haemonetics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Haemonetics stock have an average target of 103.11, with a low estimate of 85 and a high estimate of 116. The average target predicts an increase of 61.56% from the current stock price of 63.82.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 18, 2025.
Analyst Ratings
The average analyst rating for Haemonetics stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $108 → $104 | Strong Buy | Maintains | $108 → $104 | +62.96% | Mar 18, 2025 |
| Raymond James | Raymond James | Strong Buy Reiterates $120 → $115 | Strong Buy | Reiterates | $120 → $115 | +80.19% | Feb 7, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $125 → $100 | Buy | Maintains | $125 → $100 | +56.69% | Feb 7, 2025 |
| Needham | Needham | Strong Buy Maintains $112 → $108 | Strong Buy | Maintains | $112 → $108 | +69.23% | Feb 7, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $108 → $95 | Buy | Maintains | $108 → $95 | +48.86% | Feb 7, 2025 |
Financial Forecast
Revenue This Year
1.37B
from 1.31B
Increased by 4.88%
Revenue Next Year
1.34B
from 1.37B
Decreased by -2.18%
EPS This Year
4.59
from 2.29
Increased by 100.42%
EPS Next Year
4.99
from 4.59
Increased by 8.72%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.4B | 1.5B | 1.6B | |
| Avg | 1.4B | 1.3B | 1.5B | |
| Low | 1.3B | 1.3B | 1.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 9.9% | 6.6% | 15.6% | |
| Avg | 4.9% | -2.2% | 8.4% | |
| Low | 1.0% | -7.3% | 3.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 4.85 | 5.35 | 6.30 | |
| Avg | 4.59 | 4.99 | 5.72 | |
| Low | 4.41 | 4.56 | 5.33 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 111.8% | 16.7% | 26.3% | |
| Avg | 100.4% | 8.7% | 14.6% | |
| Low | 92.5% | -0.6% | 6.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.